Biggest News Aggregation in the World
📰 Central Ethics News

Central Ethics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Central Ethics. Real-time updates on events, politics, business and more.

Ryvu Therapeutics got full approval to conduct Phase I/II study of RVU120 (SEL120) in patients with relapsed/refractory metastatic or advanced solid tumors in Poland

Ryvu Therapeutics got full approval to conduct Phase I/II study of RVU120 (SEL120) in patients with relapsed/refractory metastatic or advanced solid tumors in Poland News provided by Share this article Share this article KRAKOW, Poland, May 28, 2021 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical stage drug discovery and development company focusing on novel small molecule therapies that address emerging targets in oncology, announced today that its Clinical Trial Application (CTA) to...
United States Setareh Shamsili Central Ethics Committee Leukemia Lymphoma Society Therapy Acceleration Program Menarini Group Drug Administration

Ryvu Therapeutics Reports First Quarter 2021 Financial Results

Ryvu Therapeutics Reports First Quarter 2021 Financial Results News provided by Share this article Share this article KRAKOW, Poland, May 12, 2021 /PRNewswire/ -- Ryvu Therapeutics (WSE: RVU) reported today its first quarter 2021 financial results and provided a corporate update. "Q1 2021 was an eventful quarter for Ryvu and developments around RVU120 played a key role in it" - commented Pawel Przewiezlikowski, Chief Executive Officer of Ryvu. "We have submitted a clinical trial application to ...
United States Pawel Przewiezlikowski Central Ethics Committee National Center Drug Administration American Association Of Cancer Research

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science